Cardiovascular Diseases in the Silesian Region in Poland. (SILICARD)

April 24, 2017 updated by: Mariusz Gasior, Silesian Centre for Heart Diseases

Trends in the Incidence, Treatment and Prognosis of Cardiovascular Diseases in the Silesian Region in Poland. SILesIan CARdiovascular Database (SILICARD)

The Silesian Cardiovascular Database is an observational study of all patients hospitalized due to cardiovascular diseases. The date include information on the clinical characteristics, treatment modalities and prognosis in this population.

The data include information on all the applicable diagnostic and therapeutic procedures, prognosis and hospitalization costs. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.

Study Overview

Status

Unknown

Conditions

Detailed Description

The Silesian Cardiovascular Database is an prospective observational study patients who were hospitalized in the Silesian region in Poland due to cardiovascular diseases from 1st January 2006.

The aim of the study is to collect and analyze all epidemiological data, diagnostic and therapeutic procedures, in-hospital and long-term prognosis, hospitalization costs of these patients. Likewise, data have been collected specialist care outpatient visits and primary health care patients were hospitalized.

For the analysis were included patients hospitalized in the cardiology, cardiac surgery , diabetes, vascular surgery wards and who were hospitalized for cardiac diagnosis in the wards of internal medicine and intensive care.

The Silesian Cardiovascular Database was created based on the agreement between Silesian Centre for Heart Diseases in Zabrze and the Regional Department of National Health Fund in Katowice in order to conduct analyses and prepare scientific elaborations on the group of patients with circulatory system diseases. Data elaboration and preparation for analyses was conducted by the Science Department of Silesian Centre for Heart Diseases and the Department of Biostatistics of Medical University of Silesia.

Study Type

Observational

Enrollment (Anticipated)

10000000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Poland
      • Zabrze, Poland, 41-800
        • Recruiting
        • Silesian Center for Heart Diseases
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is formed by all patients hospitalized in the Silesian region in Poland due to cardiovascular diseases from 1st January 2006.

Description

Inclusion Criteria:

  • each hospitalisation in the departments of: cardiology, cardiac surgery, diabetology and vascular surgery,
  • hospitalisation with cardiological diagnosis in the departments of internal medicine and intensive care.

Exclusion Criteria:

  • hospitalisations of patients from beyond Silesia Province,
  • patients at the age below18 years at the moment of admission to the hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participants with reported deaths from any cause
Time Frame: From date of inclusion until the date of death from any cause, assessed up to 1 year
From date of inclusion until the date of death from any cause, assessed up to 1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Trends in the number of hospitalization due to cardiovascular diseases
Time Frame: 1 year
1 year
Trends in the number of diagnostic and therapeutic procedures
Time Frame: 1 year
1 year
Number of participants with reported rehospitalization
Time Frame: From date of inclusion until the date of first event, assessed up to 1 year
From date of inclusion until the date of first event, assessed up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Silesian Centre for Heart Diseases

Investigators

  • Principal Investigator: Mariusz Gasior, Prof., PhD, 3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland
  • Study Chair: Damian Pres, MD, 3rd Chair and Department of Cardiology, Silesian Center for Heart Diseases, Zabrze, Poland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2006

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

April 4, 2016

First Submitted That Met QC Criteria

April 14, 2016

First Posted (Estimate)

April 19, 2016

Study Record Updates

Last Update Posted (Actual)

April 25, 2017

Last Update Submitted That Met QC Criteria

April 24, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SCD016

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe